BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17421047)

  • 1. Functional genome-wide analysis of antibody producing NS0 cell line cultivated at different temperatures.
    Swiderek H; Al-Rubeai M
    Biotechnol Bioeng; 2007 Oct; 98(3):616-30. PubMed ID: 17421047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
    Krampe B; Swiderek H; Al-Rubeai M
    Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and transcriptomic analysis of NS0 cell response during exposure to hypoxia.
    Swiderek H; Logan A; Al-Rubeai M
    J Biotechnol; 2008 Mar; 134(1-2):103-11. PubMed ID: 18291545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
    Khoo SH; Falciani F; Al-Rubeai M
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
    Wu MH; Dimopoulos G; Mantalaris A; Varley J
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale gene expression analysis of cholesterol dependence in NS0 cells.
    Seth G; Philp RJ; Denoya CD; McGrath K; Stutzman-Engwall KJ; Yap M; Hu WS
    Biotechnol Bioeng; 2005 Jun; 90(5):552-67. PubMed ID: 15830340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
    Veraitch FS; Al-Rubeai M
    Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.
    Ho Y; Varley J; Mantalaris A
    Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
    Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
    Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
    Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
    Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional response of Escherichia coli to temperature shift.
    Gadgil M; Kapur V; Hu WS
    Biotechnol Prog; 2005; 21(3):689-99. PubMed ID: 15932244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular portrait of high productivity in recombinant NS0 cells.
    Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS
    Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis of mouse myeloma cell lines expressing therapeutic antibodies.
    Dorai H; Li K; Huang CC; Bittner A; Galindo J; Carmen A
    Biotechnol Prog; 2007; 23(4):911-20. PubMed ID: 17592857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells.
    Ibarra N; Watanabe S; Bi JX; Shuttleworth J; Al-Rubeai M
    Biotechnol Prog; 2003; 19(1):224-8. PubMed ID: 12573029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities.
    Alete DE; Racher AJ; Birch JR; Stansfield SH; James DC; Smales CM
    Proteomics; 2005 Dec; 5(18):4689-704. PubMed ID: 16247733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of the transcriptional response of murine hybridomas to osmotic shock.
    Shen D; Sharfstein ST
    Biotechnol Bioeng; 2006 Jan; 93(1):132-45. PubMed ID: 16196057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.